Description
SPRINGER Gut-Liver Interactions Basic And Clinical Concepts by M. ZEITZ
This book, the proceedings of the Falk Symposium No. 146 'Gut-Liver Interactions: Basic and Clinical Concepts', held in Innsbruck, Austria, on March 11-12, 2005, brings together gastroenterologists and hepatologists both at a clinical and a basic scientific level. Topics have been structured in such a way to be of interest to both clinicians and basic scientists. The main focus of the book is to highlight the role of the immune system in gut and liver diseases and potential interactions of the gut and the liver respectively. Special emphasis is based on the importance of the gut flora in intestinal and also in liver diseases. The role of NOD2 is one of the very best examples demonstrating the importance, not only in inflammatory bowel diseases, but also diseases well beyond this barrier. Such intense interactions between gastroenterologists and hepatologists, as shown through this book, might boost and stimulate scientific ideas and research in other unexpected areas. List of principal contributors.-List of chairpersons.-Preface SECTION I: GENETICS AND IMMUNOLOGY IN INFLAMMATORY BOWEL DISEASES:1 Inflammatory bowel disease genotypes and phenotypes.-2 Abnormalities of cytokine regulation in the inflammatory bowel diseases.-3 Dendritic cells: key players in inflammatory bowel disease.-4 Lipids and inflammatory bowel disease: microsomal triglyceride transfer protein -- the new dimension?.-5 The intestinal epithelium and inflammatory bowel disease.-SECTION II: EVIDENCE-BASED TREATMENT IN INFLAMMATORY BOWEL DISEASE:6 Evidence-based therapy with aminosalicylates.-7 The practical use of steroids in inflammatory bowel disease.-8 Immunosuppressants: clinical use and molecular mechanism of action.-9 Biologicals: old and new ones.-SECTION III: DIFFICULT CASES IN INFLAMMATORY BOWEL DISEASES: 10 Management of extraintestinal disease in inflammatory bowel disease.-SECTION IV: INNATE IMMUNITY -- MICROBIAL PRODUCTS:11 Immunomodulatory properties of the gut microflora.-12 Defensis and other antimicrobial mediators.-13 State of the art lecture: Post-infectious irritable bowel syndrome: role of inflammation and gut flora.-SECTION V: GUT-LIVER INTERACTIONS -- BASIC AND CLINICAL ASPECTS: 14 The liver and its contribution to induction of oral tolerance.-15 Molecular regulation of lymphocyte homing between the liver and the gut.-16 Modern concepts of coeliac disease pathogenesis.-17 Hepatobiliary manifestations in inflammatory bowel disease.-SECTION VI: PRIMARY BILIARY CIRRHOSIS, CHOLESTASIS AND AUTOIMMUNE LIVER DISEASE: 18 Primary biliary cirrhosis and biliary destruction: 2005; a liver odyssey.-19 Primary biliary cirrhosis: clinical aspects.-20 Molecular mechanisms of cholestasis.-SECTION VII: PRIMARY SCLEROSING CHOLANGITIS, ALCOHOLIC STEATOHEPATITIS, NON-ALCOHOLIC STEATOHEPATITIS: 21 Basic concepts in primary sclerosing cholangitis: what can we learn from studies of its genetic basis.-22 Clinical concepts in primary sclerosing cholangitis.-23 Alcoholic liver diseases.-24 Should non-alcoholic fatty liver disease be treated differently in elderly patients?.-SECTION VIII: LIVER FAILURE AND TRANSPLANTATION: 25 Acute liver failure -- mechanisms of liver cell destruction.-26 Clinical management of acute liver failure.-27 Liver and bowel transplantation in 2005.-28 Established and novel methods for treating inflammatory diseases by inhibition of cytokines.-Index